Aspirin in patients with previous percutaneous coronary intervention undergoing noncardiac surgery

Annals of Internal Medicine

Volumn 168, Issue 4, 2018, Pages 237-244

  Graham, Michelle M ^a   Sessler, Daniel I ^b   Parlow, Joel L ^c   Biccard, Bruce M ^d   Guyatt, Gordon ^e   Leslie, Kate ^f   Chan, Matthew T V ^g   Meyhoff, Christian S ^h   Xavier, Denis ⁱ   Sigamani, Alben ^j   Kumar, Priya A ^k   Mrkobrada, Marko ^l   Cook, Deborah J ^e   Tandon, Vikas ^m   Alvarez Garcia, Jesus ⁿ   Villar, Juan Carlos ^o   Painter, Thomas W ^p   Landoni, Giovanni ^q   Fleischmann, Edith ^r   Lamy, Andre ^s   Whitlock, Richard ^s   Le Manach, Yannick ^s   Aphang Lam, Meylin ^t   Cata, Juan P ^u   Gao, Peggy ^s   Terblanche, Nicolaas C S ⁱ   Ramana, Pamidimukkala V ^v   Jamieson, Kim A ^w   Bessissow, Amal ^x   Mendoza, Gabriela R ^y   Ramirez, Silvia ^z   Diemunsch, Pierre A ^aa   Yusuf, Salim ^s   Devereaux, P J ^s   more..

^a UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^b LERNER RESEARCH INSTITUTE   (United States)

^c QUEEN S UNIVERSITY   (Canada)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e HAMILTON HEALTH SCIENCES   (Canada)

^f ROYAL MELBOURNE HOSPITAL   (Australia)

^g CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^h UNIVERSITY OF COPENHAGEN   (Denmark)

ⁱ Department of Pharmacology and Division of Clinical Research and Training ^*  (Australia)

^j Multispecialty Hospital Shaw Mazumdar Medical Centre   (India)

^k UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

^l WESTERN UNIVERSITY   (Canada)

^m MCMASTER UNIVERSITY   (Canada)

ⁿ UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^o FUNDACIÓN CARDIOINFANTIL INSTITUTO DE CARDIOLOGÍA   (Colombia)

^p ROYAL ADELAIDE HOSPITAL   (Australia)

^q SAN RAFFAELE HOSPITAL   (Italy)

^r MEDICAL UNIVERSITY OF VIENNA   (Austria)

^s HAMILTON GENERAL HOSPITAL   (Canada)

^t HOSPITAL NACIONAL ARZOBISPO LOAYZA   (Peru)

^u UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^v CARE Hospital   (India)

^w AUCKLAND CITY HOSPITAL   (New Zealand)

^x MONTREAL GENERAL HOSPITAL   (Canada)

^y HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^z HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^aa HÔPITAL DE HAUTEPIERRE   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 10A INHIBITOR; CLONIDINE; NONSTEROID ANTIINFLAMMATORY AGENT; THIENOPYRIDINE DERIVATIVE; THROMBIN; WARFARIN; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; BIOLOGICAL MARKER;

AGED; ALL CAUSE MORTALITY; ARTICLE; ATHEROSCLEROSIS; BLEEDING; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT HISTORY OF THERAPY; PERCUTANEOUS CORONARY INTERVENTION; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SURGICAL PATIENT; BLOOD; CHEMICALLY INDUCED; CLINICAL TRIAL; COMBINATION DRUG THERAPY; DRUG ADMINISTRATION; MIDDLE AGED; POSTOPERATIVE COMPLICATION; SURGERY; TREATMENT OUTCOME;

AGED; ANTIHYPERTENSIVE AGENTS; ASPIRIN; BIOMARKERS; CLONIDINE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; SURGICAL PROCEDURES, OPERATIVE; TREATMENT OUTCOME;

EID: 85042326412     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M17-2341     Document Type: Article

References (26)

1. Weiser TG, Haynes AB, Molina G, et al. Estimate of the global volume of surgery in 2012: An assessment supporting improved health outcomes. Lancet. 2015;385 Suppl 2:S11. [PMID: 26313057] doi:10.1016/S0140-6736(15)60806-6.
2. Devereaux PJ, Chan M, Eikelboom J. Major vascular complications in patients undergoing noncardiac surgery: The magnitude of the problem, risk prediction, surveillance, and prevention. In: Yusuf S, Cairns JA, Camm AJ, Fallen EL, Gersh BJ, eds. Evidence-Based Cardiology. 3rd ed. London: BMJ Books; 2009:47-62.
3. Mackey WC, Fleisher LA, Haider S, et al. Perioperative myocardial ischemic injury in high-risk vascular surgery patients: incidence and clinical significance in a prospective clinical trial. J Vasc Surg. 2006; 43:533-8. [PMID: 16520168].
4. Devereaux PJ, Xavier D, Pogue J, et al; POISE (PeriOperative ISchemic Evaluation) Investigators. Characteristics and short-Term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery: A cohort study. Ann Intern Med. 2011; 154:523-8. [PMID: 21502650] doi:10.7326/0003-4819-154-8-201104190-00003.
5. Berger PB, Kleiman NS, Pencina MJ, et al; EVENT Investigators. Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry. JACC Cardiovasc Interv. 2010;3:920-7. [PMID: 20850090] doi:10.1016/j.jcin.2010.03.021.
6. Kaluza GL, Joseph J, Lee JR, Raizner ME, Raizner AE. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol. 2000;35:1288-94. [PMID: 10758971].
7. Cruden NL, Harding SA, Flapan AD, et al; Scottish Coronary Revascularisation Register Steering Committee. Previous coronary stent implantation and cardiac events in patients undergoing noncardiac surgery. Circ Cardiovasc Interv. 2010;3:236-42. [PMID: 20442357] doi:10.1161/CIRCINTERVENTIONS.109.934703.
8. Wijeysundera DN, Wijeysundera HC, Yun L, et al. Risk of elective major noncardiac surgery after coronary stent insertion: A population-based study. Circulation. 2012;126:1355-62. [PMID: 22893606] doi:10.1161/CIRCULATIONAHA.112.102715.
9. Egholm G, Kristensen SD, Thim T, et al. Risk associated with surgery within 12 months after coronary drug-eluting stent implantation. J Am Coll Cardiol. 2016;68:2622-32. [PMID: 27978946] doi:10.1016/j.jacc.2016.09.967.
10. Devereaux PJ; POISE-2 Investigators. Rationale and design of the PeriOperative ISchemic Evaluation-2 (POISE-2) trial: An international 2 × 2 factorial randomized controlled trial of acetyl-salicylic acid vs. placebo and clonidine vs. placebo in patients undergoing noncardiac surgery. Am Heart J. 2014;167:804-9. [PMID: 24890528] doi:10.1016/j.ahj.2014.01.007.
11. Devereaux PJ, Mrkobrada M, Sessler DI, et al; POISE-2 Investigators. Aspirin in patients undergoing noncardiac surgery.NEngl JMed. 2014;370:1494-503. [PMID: 24679062] doi:10.1056/NEJMoa1401105.
12. Devereaux PJ, Sessler DI, Leslie K, et al; POISE-2 Investigators. Clonidine in patients undergoing noncardiac surgery. N Engl J Med. 2014;370:1504-13. [PMID: 24679061] doi:10.1056/NEJMoa1401106.
13. Duceppe E, Parlow J, MacDonald P, et al. Canadian Cardiovascular Society guidelines on perioperative cardiac risk assessment and management for patients who undergo noncardiac surgery. Can J Cardiol.2017;33:17-32.[PMID:27865641]doi:10.1016/j.cjca.2016.09.008.
14. Fleisher LA, Fleischmann KE, Auerbach AD, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130:e278-e333. [PMID: 25085961] doi:10.1161/CIR.0000000000000106.
15. Childers CP, Maggard-Gibbons M, Shekelle PG. Antiplatelet therapy in patients with coronary stents undergoing elective noncardiac surgery: continue, stop, or something in between? JAMA. 2017; 318:120-1. [PMID: 28628711] doi:10.1001/jama.2017.7845.
16. Devereaux PJ, Eikelboom J. Insights into myocardial infarction after noncardiac surgery in patients with a prior coronary artery stent [Editorial]. Br J Anaesth. 2016;116:584-6. [PMID: 27106960] doi:10.1093/bja/aew111.
17. Holcomb CN, Graham LA, Richman JS, Itani KM, Maddox TM, Hawn MT. The incremental risk of coronary stents on postoperative adverse events: A matched cohort study. Ann Surg. 2016;263:924- 30. [PMID: 25894416] doi:10.1097/SLA.0000000000001246.
18. Mahmoud KD, Sanon S, Habermann EB, et al. Perioperative cardiovascular risk of prior coronary stent implantation among patients undergoing noncardiac surgery. J Am Coll Cardiol. 2016;67:1038- 49. [PMID: 26940923] doi:10.1016/j.jacc.2015.11.063.
19. Cruden NL, Harding SA, Newby DE. Coronary stent thrombosis in the perioperative period [Editorial]. BMJ. 2008;337:a2074. [PMID: 19029174] doi:10.1136/bmj.a2074.
20. Serruys PW, Kutryk MJ, Ong AT. Coronary-Artery stents. N Engl J Med. 2006;354:483-95. [PMID: 16452560].
21. Bangalore S, Silbaugh TS, Normand SL, Lovett AF, Welt FG, Resnic FS. Drug-eluting stents versus bare metal stents prior to noncardiac surgery. Catheter Cardiovasc Interv. 2015;85:533-41. [PMID: 25059742] doi:10.1002/ccd.25617.
22. Saia F, Belotti LM, Guastaroba P, et al. Risk of adverse cardiac and bleeding events following cardiac and noncardiac surgery in patients with coronary stent: how important is the interplay between stent type and time from stenting to surgery? Circ Cardiovasc Qual Outcomes. 2016;9:39-47. [PMID: 26646819] doi:10.1161/CIRCOUTCOMES.115.002155.
23. Hawn MT, Graham LA, Richman JS, Itani KM, Henderson WG, Maddox TM. Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents. JAMA. 2013;310:1462- 72. [PMID: 24101118] doi:10.1001/jama.2013.278787.
24. Albaladejo P, Marret E, Samama CM, et al. Non-cardiac surgery in patients with coronary stents: The RECO study. Heart. 2011;97: 1566-72. [PMID: 21791513] doi:10.1136/hrt.2011.224519.
25. Mantz J, Samama CM, Tubach F, et al; Stratagem Study Group. Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non-cardiac surgery: The multicentre, randomized, blinded, placebo-controlled, STRATAGEM trial. Br J Anaesth. 2011;107:899-910. [PMID: 21873632] doi:10 .1093/bja/aer274.
26. Sun X, Briel M, Busse JW, You JJ, Akl EA, Mejza F, et al. Credibility of claims of subgroup effects in randomised controlled trials: systematic review. BMJ. 2012;344:e1553. [PMID: 22422832] doi:10 .1136/bmj.e1553.